EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers

Jiaxuan Chen iD, Dandan Zhu, Baoping Lian, Kangjie Shi, Peng Chen, Ying Li, Wenyi Lin, Ling Ding iD, Qiulin Long, Yang Wang, Erik Laurini iD, Wenjun Lan und 8 weitere

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2220787120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Jiaxuan Chen und 19 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, Center of Advan…. Hauptthemen laut MEDLINE: Dendrimers, Nucleic Acids, Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ligue Contre le Cancer, Agence Nationale de la Recherche, National Key Research & Development Program of China for International S&T Cooperation Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid therapeutics are becoming an important drug modality, offering the unique opportunity to address “undruggable” targets, respond rapidly to evolving pathogens, and treat diseases at the gene level for precision medicine. However, nucleic acid therapeutics have poor bioavailability and are chemolabile and enzymolabile, imposing the need for delivery vectors. Dendrimers, by virtue of their well-defined structure and cooperative multivalence, represent precision delivery systems. We synthesized and studied bola-amphiphilic dendrimers for cargo-selective and on-demand delivery of DNA and small interfering RNA (siRNA), both important nucleic acid therapeutics. Remarkably, superior performances were achieved for siRNA delivery with the second-generation dendrimer, yet for DNA delivery with the third generation. We systematically studied these dendrimers with regard to cargo binding, cellular uptake, endosomal release, and in vivo delivery. Differences in size both of the dendrimers and their nucleic acid cargos impacted the cooperative multivalent interactions for cargo binding and release, leading to cargo-adaptive and selective delivery. Moreover, both dendrimers harnessed the advantages of lipid and polymer vectors, while offering nanotechnology-based tumor targeting and redox-responsive cargo release. Notably, they allowed tumor- and cancer cell-specific delivery of siRNA and DNA therapeutics for effective treatment in different cancer models, including aggressive and metastatic malignancies, outperforming the currently available vectors. This study provides avenues to engineer tailor-made vectors for nucleic acid delivery and precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DendrimersNucleic AcidsNeoplasmsHumansRNA, Small InterferingDNARNA, Double-Stranded

Stichwörter der Autor:innen

dendrimergene silencinggene transfectionnonviral vectorsnucleic acid delivery

Substanzen

DendrimersNucleic AcidsRNA, Small InterferingDNARNA, Double-Stranded

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University,…
  • Aix Marseille University, CNRS, Center Interdisciplinaire de Nanoscience de Marseille, UMR 7325, «Equipe Labellisée Ligue Contre le Cancer», Marseille 13288, France.
  • Hubei Gedian Humanwell Pharmaceutical Co. Ltd., E-zhou 436070, P. R. China.
  • Department of Engineering and Architecture, Molecular Biology and Nanotechnology Laboratory, University of Trieste, Trieste 34127, Italy.
  • Aix Marseille University, INSERM, Centre de Recherche en Cancérologie de Marseille, Institute Pauli-Calmettes, Marseille 13273, France.
  • Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-136, Poland.

ORCID-Profile: Jiaxuan Chen, Ling Ding, Erik Laurini, Aura Tintaru, Can Zhang, Sabrina Pricl, Juan Iovanna, Ling Peng

Förderung

  • Ligue Contre le Cancer
  • Agence Nationale de la Recherche
  • National Key Research & Development Program of China for International S&T Cooperation Projects
  • MOST | National Natural Science Foundation of China
  • State Key Laboratory of Natural Medicines at China Pharmaceutical University
  • H2020 NMBP 'SAFE-N-MEDTECH'

Zitieren

APA

Chen, J., Zhu, D., Lian, B., Shi, K., Chen, P., Li, Y., Lin, W., Ding, L., Long, Q., Wang, Y., Laurini, E., Lan, W., Li, Y., Tintaru, A., Ju, C., Zhang, C., Pricl, S., Iovanna, J., Liu, X., & Peng, L. (2023). Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2220787120

Vancouver

Chen J, Zhu D, Lian B, Shi K, Chen P, Li Y, et al. Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2220787120

BibTeX
@article{Chen2023,
  author = {Chen, Jiaxuan and Zhu, Dandan and Lian, Baoping and Shi, Kangjie and Chen, Peng and Li, Ying and Lin, Wenyi and Ding, Ling and Long, Qiulin and Wang, Yang and Laurini, Erik and Lan, Wenjun and Li, Yun and Tintaru, Aura and Ju, Caoyun and Zhang, Can and Pricl, Sabrina and Iovanna, Juan and Liu, Xiaoxuan and Peng, Ling},
  title = {Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2220787120}
}
Kostenlos starten →